Lungpacer Medical, Inc. Receives Expedited Access Pathway Designation From FDA For The Lungpacer Diaphragm Pacing System

Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that it has received Expedited Access Pathway (EAP) designation from the U.S. Food and Drug Administration (FDA).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news